Verrica Pharmaceuticals (VRCA)
(Real Time Quote from BATS)
$6.93 USD
-0.12 (-1.70%)
Updated Jul 30, 2024 01:18 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
VRCA 6.93 -0.12(-1.70%)
Will VRCA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for VRCA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VRCA
Zevra Therapeutics (ZVRA) Surges 21.9%: Is This an Indication of Further Gains?
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
VRCA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates
Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates
Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?
Other News for VRCA
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today
Analysts Offer Insights on Healthcare Companies: Xtant Medical Holdings (XTNT) and Verrica Pharmaceuticals (VRCA)
Biotech Alert: Searches spiking for these stocks today